Pioglitazone Hydrochloride Tablet
Product Images NDC 82009-104

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 82009-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)

A line graph depicting mean change from baseline for HbA1c over a 26-week placebo-controlled study. The x-axis shows weeks (0 to 26), and the y-axis shows mean change values ranging approximately from -2.0 to 1.0. Four lines represent placebo, 15 mg, 30 mg, and 45 mg doses, with the highest dose showing the greatest decrease in HbA1c over time.*

FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablet Bottle))

Label for Pioglitazone Tablets USP 15 mg oral tablets from Quallent Pharmaceuticals Health LLC. The label indicates a 500 tablet count with storage instructions (20° to 25°C) and dispensing guidance. Manufactured by Aurobindo Pharma Limited, Hyderabad, India, for Quallent Pharmaceuticals Health LLC, Grand Cayman. Features a barcode and space for GTIN, serial number, expiry date, and lot number.*

FDA Label Image

Package Label-principal Display Panel (30 mg (500 Tablets Bottle))

Label for Pioglitazone Tablets, USP 30 mg oral tablets by Quallent Pharmaceuticals Health LLC. The label indicates a package count of 500 tablets, includes storage instructions (20° to 25°C), and cautions such as keeping the container tightly closed and out of reach of children. The label also lists manufacturer details for Aurobindo Pharma Limited, India, with a barcode and a designated coding area for GTIN, serial number, expiry date, and lot information.*

FDA Label Image

Package Label-principal Display Panel (45 mg (500 Tablets Bottle))

Label for Pioglitazone Tablets USP 45 mg in a bottle of 500 tablets by Quallent Pharmaceuticals Health LLC. The label notes pioglitazone hydrochloride USP equivalent to 45 mg per tablet, with storage instructions and a pharmacist medication guide advisory. Manufactured by Aurobindo Pharma Limited, India, and Quallent Pharmaceuticals Health LLC, Cayman Islands. Includes NDC 82009-105-05 and a barcode.*

FDA Label Image

Chemical Structure (Pioglitazone Str)

Chemical structure of pioglitazone hydrochloride, showing molecular components and arrangement including aromatic rings, an ether linkage, a thiazolidinedione moiety, and an associated hydrochloride group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.